• Explore /
  • Poster
  • / Study EV-103: New randomized cohort testing enfortumab vedotin as monotherapy or in combination with pembrolizumab in locally advanced or metastatic urothelial cancer.

Study EV-103: New randomized cohort testing enfortumab vedotin as monotherapy or in combination with pembrolizumab in locally advanced or metastatic urothelial cancer.

Abstract Video & Slides Poster

Authors

null

Nataliya Mar

UC Irvine Medical Center, Orange, CA

Nataliya Mar , Terence W. Friedlander , Christopher J. Hoimes , Thomas W. Flaig , Mehmet Asim Bilen , Arjun Vasant Balar , Elizabeth Henry , Sandy Srinivas , Jonathan E. Rosenberg , Daniel Peter Petrylak , Earle Frederick Burgess , Jaime R. Merchan , Scott T. Tagawa , Anne-Sophie Carret , Joyce Leta Steinberg , Marya F. Chaney , Matthew I. Milowsky

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Clinical Trial Registration Number

NCT03288545

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS5092)

DOI

10.1200/JCO.2020.38.15_suppl.TPS5092

Abstract #

TPS5092

Poster Bd #

161

Abstract Disclosures

Similar Posters

First Author: Jonathan E. Rosenberg

First Author: Jonathan E. Rosenberg

First Author: Peter H. O'Donnell

First Author: Bradley Alexander McGregor